Ingolstaedter Landstrasse 1 85764 Neuherberg Germany Phone: +49 89 3187-2047 Email: siegfried.ussar@helmholtz-munich.de White adipose tissue expansion, resulting in body weight gain, is generally viewed unfavorably due to esthetic and health reasons. The latter results from the general understanding that excessive accumulation of fat in adipose tissues results in impaired adipose function predisposing the organism to the development of systemic insulin resistance, the metabolic syndrome, and a host of other comorbidities that lead to a significant rise in mortality risk and impose social and economic burdens on individuals and the society. Recent societal changes such as the body positivity movement, paired with research findings identifying a potentially healthy obese phenotype aimed to change our perception and definition of excessive body fat. However, various clinical studies have questioned the existence of a healthy obese phenotype, with most recent data suggesting that a metabolically healthy obesity is merely an intermediate state in the progression from weight gain to the development of insulin resistance and the metabolic syndrome [1]. To this end, most research articles aim to identify factors underlying the detrimental metabolic consequences of body weight gain focusing on the negative consequences of increased adiposity. However, adipose tissue, in addition to its important endocrine function, remains essential to maintain homeostasis during times of energy surplus and shortage, in ensuring an ample supply of energy. In addition, the role of adipose tissue regulating the immune system in the host defense against pathogens is also an emerging area of research [2].In contrast to other organs, adipose tissue is not a single discrete organ but organized in individual depots distributed throughout the body [3]. Thus, the overarching theme of the articles of this research topic is to highlight that not all adipose tissue expansion is the same. It is especially important to consider the specialized white adipose tissue depots, such as in the bone marrow fat (Burkhardt et al.,The benefits of adipocyte metabolism in bone health and regeneration), the dermal adipose tissue [4; 5], or epiploic fat surrounding the human colon [6; 7] exist that appear to function beyond energy storage, regulating host immune defense, and bone and stem cell function. Adipose depots expand in response to increased energy intake, but adipocyte differentiation, growth and turnover are also regulated by other local paracrine factors, such as those from the tissue resident immune cells [8].These processes are critical to maintain tissue homeostasis, the adipose tissue being arguably one of the most plastic tissues of the organism [9].In addition, there are tremendous differences in the metabolic consequences of adipose tissue expansion depending on the affected depot/ anatomical location and its nature (hypertrophy vs. hyperplasia). This is important as the mode of fat mass gain and adipose tissue expansion differs greatly Overall, there is a clear consensus that adipose tissue and to some extent also adipose expansion is essential for a functional metabolism. Moreover, a picture is emerging indicating that continuous triglyceride turnover is a key element in maintaining adipocyte function and static storage of triglycerides associates with adipocyte dysfunction. However, excessive and uncontrolled lipolysis can induce a local inflammatory response resulting in fibrosis that limits the ability of individual adipocytes to expand [12]. This causes adipocyte death, further inflammation and spillover of lipids to other organs such as the skeletal muscle and the liver. Future studies, will need to harvest the insights from recent single cell sequencing approaches describing adipocyte and stromal heterogeneity to develop novel transgenic technologies to study adipocyte growth in a depot and potentially single adipocyte, preadipocyte, or immune cell specific manner. We are convinced that retaining adipocyte function and its ability to expand will be promising approaches to retain or restore insulin sensitivity in the context of obesity, by maintaining some sort of healthy obesity, and potentially further enhancing the efficacy of currently available weight loss drugs targeting the central nervous system.
8 Authors
- LB
Lisa-Marie Burkhardt
Julius Wolff Institute, Germany
- CH
Christian H. Bucher
Julius Wolff Institute, Germany
- JL
Julia Löffler
Julius Wolff Institute, Germany
- CR
Charlotte Rinne
Department of Adipocyte Development and Nutrition, Germany
- GN
Georg N. Duda
Julius Wolff Institute, Germany
- SG
Sven Geissler
Julius Wolff Institute, Germany
- TJ
Tim J. Schulz
Department of Adipocyte Development and Nutrition, Germany
- KS
Katharina Schmidt-Bleek
Julius Wolff Institute, Germany
7,257 views
23 citations
18,291 views
69 citations
4,583 views
12 citations
3 Authors
- EB
Emma Börgeson
Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden
- JB
Jeremie Boucher
The Lundberg Laboratory for Diabetes Research, Sweden
- CE
Carolina E. Hagberg
Division of Cardiovascular Medicine, Sweden
8,269 views
16 citations
